-Dow Jones
Argus Research Maintains Buy on FedEx, Raises Price Target to $330
Argus Research analyst John Eade maintains FedEx (NYSE:FDX) with a Buy and raises the price target from $305 to $330.
Related Posts
Harmony Biosciences Initiates A Phase 2 Clinical Trial In Myotonic Dystrophy
Harmony Biosciences Holdings, Inc. ("Harmony") (NASDAQ:HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological disorders
BMO Capital Downgrades Domtar to Market Perform, Raises Price Target to $55.5
BMO Capital analyst Mark Wilde downgrades Domtar (NYSE:UFS) from Outperform to Market Perform and raises the price target from $53 to $55.5.
Piper Sandler Maintains Underweight on Canopy Gwth, Lowers Price Target to $4
Piper Sandler analyst Michael Lavery maintains Canopy Gwth (NASDAQ:CGC) with a Underweight and lowers the price target from $6 to $4.